Andrew Moin - Director at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Moin since 12/22/2023

Holdings reported by Andrew Moin for SAB Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series A-2 Convertible Preferred Stock 28.4K $28.4M $1,000.00 Nov 24, 2023 Indirect Common Stock
Common Stock 4.58M $4.03M $0.88 Nov 24, 2023 Indirect
Preferred Tranche C Warrants 52.1K Nov 10, 2023 Indirect Series A-3 Preferred Stock
Preferred Tranche B Warrants 20.8K Nov 10, 2023 Indirect Series A-3 Preferred Stock
Preferred Tranche A Warrants 0 Nov 13, 2023 Indirect Series A-1 and/or A-3 Convertible Preferred Stock
Series A-1 Convertible Preferred Stock 0 $1,000.00 Nov 24, 2023 Indirect Common Stock or Series A-2 Convertible Preferred Stock

Transactions reported by Andrew Moin for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.